Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro & Ophthalmology Summit 2025
Provided By PR Newswire
Last update: May 16, 2025
WASHINGTON, May 16, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in investor meetings at the Mizuho Neuro & Ophthalmology Summit 2025 in New York City on Wednesday, May 21, 2025.
Read more at prnewswire.com4.84
-0.3 (-5.84%)
Find more stocks in the Stock Screener
VNDA Latest News and Analysis
